- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Latest News
A population-based study, published in the Journal of the American Medical Association (JAMA), has found flu vaccination...
Read More
Read More
Delta, also known as B.1.617.2, has spread to more than 60 countries over the past six months and triggered travel curbs...
Read More
Read More
Vaccines available in India - Covaxin, Covishield and Sputnik V - have not been approved yet for use on children. ...
Read More
Read More
The Union health ministry’s directorate general of health services (DGHS) has revised the Covid management guidelines...
Read More
Read More
Several developing and under-developed nations would have breathed a sigh of relief after the US rolled out its...
Read More
Read More
GENEVA (AP) — The World Health Organization’s top vaccines expert said Thursday that immunizing children against...
Read More
Read More
The court said some urgent hand-holding is required for manufacturing vaccines which is missing because of "fear...
Read More
Read More
The B.1.617 variant of the virus has been dubbed a triple mutant variant since it is split into three...
Read More
Read More
Pfizer said in a statement that it is aware of the Israeli observations of myocarditis, noting that no causal link to...
Read More
Read More
New Delhi: India's decision to ban vaccine exports has had a severe impact on 91 nations dependent on Serum Institute of...
Read More
Read More
A single-dose Covid vaccine made by Janssen has been approved for use in the UK by the medicines regulator. The...
Read More
Read More
India will launch a study on whether a single dose of Covishield, the Oxford-AstraZeneca vaccine locally manufactured by...
Read More
Read More